Goldman Sachs Group Inc Illumina, Inc. Call Options Transaction History

Goldman Sachs Group Inc

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 13, 2024	BUY	$101.05 - $133.57 $788,190 - $1.04 Million	7,800 New	7,800 $814,000
Q4 2023 Feb 13, 2024	SELL	$92.79 - $142.53 $2.87 Million - $4.4 Million	-30,900 Reduced 20.82%	117,500 $16.4 Million
Q3 2023 May 14, 2024	BUY	$128.91 - $192.44 $3.98 Million - $5.95 Million	30,900 Added 26.3%	148,400 $20.4 Million
Q3 2023 Nov 14, 2023	BUY	$128.91 - $192.44 $19.1 Million - $28.6 Million	148,400 New	148,400 $20.4 Million
Q4 2021 Feb 14, 2022	BUY	$347.28 - $421.83 $902,927 - $1.1 Million	2,600 Added 30.59%	11,100 $4.22 Million
Q3 2021 Nov 10, 2021	BUY	$405.61 - $524.84 $3.45 Million - $4.46 Million	8,500 New	8,500 $3.45 Million

901

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.5B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.